Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-034005
Filing Date
2013-06-10
Accepted
2013-06-10 21:55:31
Documents
1
Period of Report
2013-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd383045.html 4  
1 FORM 4 rrd383045.xml 4 3872
  Complete submission text file 0001181431-13-034005.txt   5265
Mailing Address AMYLIN PHARMACEUTICALS INC 9360 TOWNE CENTRE DR SAN DIEGO CA 92121
Business Address
FOLETTA MARK G (Reporting) CIK: 0001236389 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35670 | Film No.: 13904864

Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Issuer) CIK: 0001505512 (see all company filings)

EIN.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations